About Compvide
Compvide is a biotechnology company focused on advancing complement system science through rigorous assay development, translational research, and diagnostic innovation. The company's proprietary CIMED diagnostic platform is a family of pathway-specific ELISA kits for complement activity measurement and drug monitoring.
Compvide's work is centered on generating reliable, physiologically relevant complement data to support drug development, precision medicine, and next-generation diagnostic platforms.
Vision
To become a global leader in complement diagnostics, driving precision medicine that improves patient outcomes, minimizes treatment waste, and accelerates the development of immune-targeted therapies.
Mission
To advance personalized medicine by delivering accurate, high-fidelity complement and immune diagnostics that empower clinicians to evaluate drug response, optimize treatment decisions, and reduce unnecessary healthcare spending.
Our Principles
Patient-Centered Impact
We design diagnostics that help clinicians personalize therapy, prevent overtreatment, and improve quality of life for patients worldwide.
Accountability & Ethics
We take responsibility for the integrity of our science, the clarity of our communication, and the impact of our technology on healthcare.
Leadership Team
Compvide is led by a multidisciplinary team with deep expertise in complement biology, translational research, diagnostics, and clinical development.
Scientific Advisory Board
World-renowned experts guiding our scientific and translational strategy.